| Literature DB >> 31277482 |
Przemysław Łukasz Kowalczewski1, Anna Olejnik2, Wojciech Białas2, Iga Rybicka3, Magdalena Zielińska-Dawidziak4, Aleksander Siger4, Piotr Kubiak2, Grażyna Lewandowicz2.
Abstract
Potato protein is recognized as one of the most valuable nonanimal proteins due to the high content of essential amino acids. So far, it has not been used in human nutrition on a large scale due to technological limitations regarding its acquisition. In this study, the protein fraction of potato juice was concentrated with the use of membrane separation. The obtained potato juice protein concentrate (PJPC) was characterized in terms of nutritional value and biological activity, and the amino acid composition, mineral content, and antioxidant properties were determined. Moreover, in vitro cytotoxic activity against cancer cells of the gastrointestinal tract was investigated. The results of the present study indicate that PJPC is an excellent source of lysine and threonine, while leucine is its limiting amino acid, with an amino acid score (AAS) of 65%. Moreover, PJPC contains substantial amounts of Fe, Mn, K, and Cu. As demonstrated experimentally, PJPC is also characterized by higher antioxidant potential than potato itself. Biological activity, however, is not limited to antioxidant activity alone. Cytotoxicity studies using a gastric cancer cell line (Hs 746T), a colon cancer cell line (HT-29), and human colon normal cells (CCD 841 CoN) proved that PJPC is characterized by selective activity against cancer cells. It can thus be concluded that the developed method of producing protein concentrate from potato juice affords a product with moderate nutritional value and interesting biological activity.Entities:
Keywords: antioxidant activity; cancer cells; chemical score; cytotoxicity; potato juice; protein composition; protein nutritional value
Year: 2019 PMID: 31277482 PMCID: PMC6683274 DOI: 10.3390/nu11071523
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Schematic diagram of the applied membrane separation system for ultrafiltration. FT-1: feed tank; V-1–5: manual diaphragm valves; P-1, 2: centrifugal pumps; HE-1: shell and tube heat exchanger; M-1–3: pressure sensors; PT-1: permeate tank; FM-1, 2: electromagnetic flowmeters; B-1: electronic balance.
Proximate composition.
| Parameter | FPJ | PJPC |
|---|---|---|
| Moisture (%) | 94.49 ± 3.21 a | 4.79 ± 0.32 b |
| Protein (g/100 g dm) | 2.37 ± 0.07 b | 63.40 ± 0.82 a |
| Ash (g/100 g dm) | 0.91 ± 0.03 b | 7.54 ± 0.27 a |
| α-chaconine (µg/100 g dm) | 990.06 ± 17.11 a | 837.81 ± 15.36 b |
| α-solanine (µg/100 g dm) | 601.24 ± 19.37 a | 438.40 ± 18.49 b |
Mean values denoted by different letters (a, b) showed statistically significant difference (p < 0.05). FPJ—fresh potato juice; PJPC—potato juice protein concentrate.
Amino acid profile and amino acid score (AAS) for adults according to standards reported by the FAO/WHO [40].
| Amino Acid | FAO/WHO Standard (mg/g) | PJPC (g/16 g N) | AAS |
|---|---|---|---|
| Essential amino acids | |||
| Histidine | 16 | 1.95 ± 0.07 | 86.3 |
| Isoleucine | 30 | 4.31 ± 0.09 | 102.0 |
| Leucine | 61 | 9.06 ± 0.11 | 64.6 |
| Lysine | 48 | 8.33 ± 0.20 | 123.1 |
| Methionine + Cystine | 23 | 3.85 ± 0.18 | 118.7 |
| Phenylalanine + Tyrosine | 41 | 10.44 ± 0.27 | 161.1 |
| Threonine | 25 | 6.24 ± 0.17 | 177.2 |
| Tryptophan | 6.6 | 1.11 ± 0.09 | 120.3 |
| Valine | 40 | 5.64 ± 0.21 | 100.0 |
| Dispensable amino acids | |||
| Alanine | - | 5.10 ± 0.30 | - |
| Arginine | - | 4.69 ± 0.11 | - |
| Aspartic acid | - | 12.74 ± 0.52 | - |
| Glutamic acid | - | 11.22 ± 0.55 | - |
| Glycine | - | 5.20 ± 0.11 | - |
| Proline | - | 5.05 ± 0.19 | - |
| Serine | - | 5.06 ± 0.21 | - |
Calculated protein efficiency ratio (PER) values of PJPC.
| Parameter | PJPC |
|---|---|
| PER1 | 3.21 ± 0.02 |
| PER2 | 3.13 ± 0.05 |
| PER3 | 1.87 ± 0.02 |
Mineral composition of PJPC.
| Mineral | Content (mg/100 g) | % PRI/AI |
|---|---|---|
| Fe | 30.5 ± 4.2 | 191 |
| Mn | 3.79 ± 0.17 | 126 |
| K | 4341 ± 271 | 124 |
| Cu | 1.14 ± 0.07 | 114 |
| Mg | 241 ± 9 | 80 |
| Ca | 118 ± 8 | 12 |
| Zn | 6.04 ± 0.11 | 60 |
| Na | 84.5 ± 4.9 | - |
Antioxidant activity expressed as the ferric-reducing antioxidant power (FRAP), Trolox equivalent antioxidant capacity (TEAC), total phenolic compounds (TPCs), and total flavonoid compounds (TFCs).
| Parameter | PJPC |
|---|---|
| FRAP (mmol g−1) | 1.41 ± 0.07 |
| TEAC (mmol g−1) | 1.53 ± 0.12 |
| TPC (mg g−1) | 5.82 ± 0.16 |
| TFC (mg g−1) | 2.10 ± 0.11 |
Cytotoxic doses of PJPC [mg/mL].
| Cell Line | IC10 | IC50 | IC90 |
|---|---|---|---|
| Hs 746T | 9.11 ± 0.96 a | 14.69 ± 0.57 a | 23.76 ± 0.65 a |
| HT-29 | 0.80 ± 0.14 c | 3.89 ± 0.21 c | 19.38 ± 2.24 b |
| CCD 841 CoN | 4.71 ± 0.57 b | 6.50 ± 0.20 b | 9.06 ± 1.19 c |
Mean values denoted by different letters (a–c) differ statistically significantly (p < 0.05).
Figure 2Changes in cell proliferation and viability upon treatment of the stomach cancer cells (Hs 746T line), colon cancer cells (HT-29 line), and colon normal cells (CCD 841 CoN line) with PJPC at concentrations ranging from 0.5 to 20 mg/mL.